Print this page Print this page      Email this page Email this page     Text Size: A  A  A     Click Here to Sign In
Home > MS Treatment > MS Treatment Options > COPAXONE® (glatiramer acetate injection)

COPAXONE®

(glatiramer acetate injection)

  • COPAXONE is approved to decrease the number of relapses and for use in people who have experienced a first attack and have lesions consistent with MS on their MRI.

View Clinical Benefits

Dosing regimen:

  • COPAXONE is self-injected seven times a week.
Clinical Benefits
CLOSE

COPAXONE® (glatiramer acetate injection) Clinical Benefits

 

  • Reduce the frequency of flare-ups
  • Delay the time to second clinical episode in people with early MS
Personalize Your Own MS ActiveSource Homepage
Register now to start using these helpful online tools.
  • My MS Memory Builder
  • My MS Calendar
  • My MS Logbook
 Create a profile 
Already have a profile? Sign In
Managing Treatment Side Effects All MS treatments have side effects. Get tips on how to manage them. Learn more
Staying on Treatment Find information on the importance of staying on treatment for MS. Learn more

Call an MS Support Specialist: 1.800.456.2255

Elan  |  Contact Us  |  Privacy Policy  |   Legal Disclaimer  |  Site Map

© 2009 Biogen Idec. All rights reserved. MSActiveSource is a registered trademark of Biogen Idec. MSActiveSource is sponsored by Biogen Idec and Elan Pharmaceuticals.

BIOGEN IDEC and the BIOGEN IDEC logo are registered trademarks of BIOGEN IDEC.
The Elan logo is a registered trademark of Elan Corporation, PLC.